Remove Stroke Remove Technology Remove Webinar
article thumbnail

Landmark Clinical Study in The Lancet Finds New AI Technology Can Predict Cardiac Events Due to Coronary Inflammation at Least 10 Years in Advance

DAIC

Caristo Diagnostics Limited has announced the results of a landmark clinical study published in The Lancet that support the ability of Caristo's CaRi-Heart AI technology to quantify coronary artery inflammation and accurately predict cardiac events. The CaRi-Heart technology is in clinical use in the UK, European Union, and Australia.

article thumbnail

Leveraging AI-Enabled Remote Cardiac Monitoring to Improve Cardiovascular Care

DAIC

By enabling the decisive shift from a reactive to a proactive cardiology model, this technology doesnt just improve patient outcomes it is also helping keep cardiovascular care sustainable and affordable. Participating hospitals will collaborate to share challenges and develop solutions through education, conferences, and webinars.